MyFinsight
Home
Blog
About
Contact
Short-term investments
$176,648K
Accounts receivable, net
$28,662K
Cash and cash
equivalents
$24,321K
Inventories
$8,817K
Prepaid expenses and
other current assets
$6,788K
Total current assets
$245,236K
Inventories, noncurrent
$23,221K
Intangible assets, net
$14,176K
Other assets
$2,653K
Property, plant and
equipment, net
$2,285K
Total assets
$287,571K
Total liabilities and
stockholders' equity
$287,571K
Total liabilities
$226,263K
Total stockholders'
equity
$61,308K
Accumulated deficit
-$355,221K
Accumulated other
comprehensive (loss) gain, net
-$96K
Term loans, net
(including related party...
$96,522K
Financing liability
$74,673K
Total current
liabilities
$49,612K
Other accrued
liabilities
$4,478K
Contract liability, net
of current portion
$978K
Additionalpaid-incapital
$416,615K
Common stock, 0.0001
par value per share...
$10K
Accounts payable and
accrued liabilities...
$48,263K
Contract liability,
current
$757K
Other current
liabilities
$592K
Accrued marketing
related expenses
$20,411K
Accrued gross-to-net
liabilities
$15,362K
Other
$5,843K
Accounts payable
$4,705K
Accrued cost of goods
sold
$1,847K
Accrued inventory
$95K
Back
Back
Balance Sheet
ARS Pharmaceuticals, Inc. (SPRY)
ARS Pharmaceuticals, Inc. (SPRY)
source: myfinsight.com